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Summary 
The biological function of a cold-adapted (ca) mutation residing on the 
PB2 gene of an influenza A/Ann Arbor/6/60 (A/AA/6/60) ca variant virus 
in the viral replication cycle at  25 ° C was studied. The viral polypeptide 
synthesis of A/AA/6/60 ea variant at 25 ° C was evident approximately 
6 hours earlier than the wild type (wt) virus and yielded twice as many 
products. The quantitative analysis of viral complementary RNA (cRNA), 
synthesized in the presence of cycloheximide, revealed tha t  A/AA/6/60 ca 
variant and a single gene reassortant tha t  contains only the PB 2 gene of 
the ca variant with remaining genes of the wt virus produced equal amount 
of cRNA at 25 ° and 33 ° C, which was an amount approximately four fold 
greater than the wt virus' cRNA synthesized at  25 ° C. These results strongly 
suggest tha t  the ca mutat ion residing on the PB2 gene of A/AA/6/60 ca 
variant affects the messenger RNA synthesis at  25 ° C in the primary 
transcription. 
Introduction 
A cold-adapted variant of A/Ann Arbor/6/60 (A/AA/6/60) influenza 
virus was developed by serial passages in primary chick kidney (PCK) cells 
by  gradually lowering the incubation temperature to 25 ° C which restricted 
the growth of the wt strain (17, 18). The A/AA/6/60 variant strain has been 
found to possess two inheritable plaquing phenotypes. One is the cold- 
adapted (ca) property which is the ability to grow to high titer at 25 ° C. 
The other is the temperature-sensitive (is) property with a shutoff tern- 
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pe ra tu re  of 37 ° or 38 ° C (16, 17, 18, 27). lgeassortants  that. possessed the  
six nonglycoprote in  genes of A/AA/6/60 var ian t  and the two glycoprotein 
genes of a wt  virus, were a t t enua t ed  to  bo th  animals and humans  (18, 21, 
27), possessed good immunogenic  qualities (5, 29, 32), and t hey  were 
genet ical ly stable (8). Thus,  the  A/AA/6/60 ca va r i an t  virus is cur ren t ly  
the most  useful mas te r  s train for  developing live influenza vaccine lines. 
Ident.ification of the  ca A/AA/6/60 va r i an t  genes responsible for  the ca 
and  ts propert ies  have been hampered  due to two commonly  encountered  
difficulties; 1. the  lack of single-gene reassor tants  bear ing the  ca or ts 
propert ies  and  2. the lack of a divers i ty  in the  gene constellat ions of re- 
assor tant  viruses. Assignment  of gene constellations using a large number  
of ca reassor tan t  clones, formed by  mat ing the  A/AA/6/60 ca va r ian t  and 
wt  viruses, suggests t ha t  the ts p rope r ty  of the ca reassor tant  is not  deter-  
mined by  a single gene of the  A/AA/6/60 ca va r ian t  (6, 7, 23). 
The  funct ion of the ca muta t ion  in the  viral  repl icat ion cycle and the  
gene(s) involved  in ca p rope r ty  of A/AA/6/60 ca va r ian t  have  ye t  to  be 
unequivocal ly  identified. Previously,  we developed ca and non ts phenotyp ic  
reassor tan t  clones using canine k idney  (MDCK) cells a t  a non-selective 
t empera tu re  of 33 ° C (23). Some of the  single-gene reassortants  t ha t  possessed 
only  RNA 2 coding for the  PB  2 gene or R N A  5 coding for the  neuraminidase  
(NA) gene of A/AA/6/60 ca var iant ,  were involved in the  ca and non ts 
phenotypes .  There  reassor tants  allowed us to  determine the  funct ion of the  
ca mu ta t ion  in viral  a t t enua t ion  in mice (24) as well as the  biological 
mechanism tha t  operates  to lower the  viral repl icat ion range to 25 ° C. 
The  present  s tudy  describes the  effects of a ca mu ta t ion  residing on 
the  P B 2  gene of A/AA/6/60 va r ian t  strain. Using the P B 2  single-gene ca 
reassor tan t  virus, we found  t h a t  the  P B  2-ca muta t ion  affects bo th  polymer-  
ase ac t iv i ty  and messenger RIgA synthesis in p r imary  t ranscr ip t ion at  
25 ° C. 
Materials and Methods 
V~ruses and Tissue Cultures 
Influenza A viruses used in the present study were a 8 PI-A/Ann Arbor/6/60 (H 2 N 2) 
cold-adapted (ca) variant (17), an A/Ann Arbor/6/60 (H2N2) wild type strain, an 
A/Alaska/6/77 (H3N2) and the ca reassortant clones of the A/Ann Arbor/6/60 ea 
variant and A/Alaska/6/77 virus (23). 
Madin-Darby canine kidney (MDCK) eelts (Flow Laboratory, 1R, oekvitle, Md.) 
were used between the 60th and 75th passage levels. The cell cultures were maintained 
in an Eagle's MEM containing 10 per cent heat-inactivated fetal calf serum and were 
used for subsequent viral growth curve and biochemical analysis. 
Viral Growth Curve Analysis 
Confluent MDCK monolayers in 25 cm 2 plastic bottles were infected with the 
viruses at a multiplicity of infection (MOI) of 1.0 plaque-forming unit (PFU) per ceil 
in double-strength Eagle's basal medium (2X Eagle's) containing 5 tzg/Inl of TPCK 
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t ryps in .  Af t e r  1 h o u r  a d s o r p t i o n  a t  r o o m  t e m p e r a t u r e ,  cu l tu res  were  w a s h e d  twice  
w i t h  5 m l  of H u n k ' s  b a l a n c e d  sa l t  so lu t ion  (HBSS) .  The  w a s h e d  cu l tu res  were  t h e n  
i n c u b a t e d  w i t h  1 ml  of d i lu t ed  ch icken  A / A n n  Arbor /6 /60  ea  v a r i a n t  a n t i s e r u m  for 
A / A n n  Arbor /6 /60  ea  v a r i a n t  a n d  for t h e  wi ld  t y p e  v i r u s ;  or w i t h  1 ml  of d i l u t ed  A/  
B a n g k o k / I / 7 9  ( I t  3 ) - E q u i n e / P r a g u e / I / 5 6  (N 7) a n t i s e r u m  for  t h e  ca  r e a s s o r t a n t  v i ruses  
( h e m a g g l u t i n a t i o n - i n h i b i t i o n  t i t e r  of 1:50) for  30 m i n u t e s  a t  r o o m  t e m p e r a t u r e  to  
neu t r a l i ze  a n y  u n p e n e t r a t e d  vi ruses .  The  an t i s e r a  were  t h e n  r e m o v e d  b y  two  wash ings  
a n d  t h e  cu l tu res  were  i n c u b a t e d  a t  25 ° or 33 ° C w i t h  2 m l  of 2 X  Eag le ' s  c o n t a i n i n g  
5 ~g /ml  of T P C K  t ryps in .  T h e  v i ru s  re leased  in to  t h e  s u p e r n a t a n t  f lu id  was  h a r v e s t e d  
ag va r ious  t i m e  in te rva l s ,  rI~qe cu l tu res  were w a s h e d  once  w i t h  5 m l  of p r e w a r m e d  
H B S S ,  fol lowed b y  a s u p p l e m e n t  w i t h  2 ml  of p r e w a r m e d  2X Eagle ' s  for f u r t h e r  
i ncuba t ion .  The  v i rus  t i t e r  in  t h e  s u p e r n a t a n t  f lu id  was e v a l u a t e d  b y  p l a q u e  as say  
on  M D C K  m o n o l a y e r  eells a t  33 °, as p r e v i o u s l y  descr ibed  (23). 
girion Associated RNA-dependent aNNA Polymerase Assay 
I n  vitro v i r ion  I~NA po lymerase  a c t i v i t y  was  a n a l y z e d  b y  t h e  m e t h o d  descr ibed  
b y  P L o ~ c g  a n d  K ~ v G  (25). A p p r o x i m a t e l y  20 lzg of pur i f i ed  v i r ion  p r o t e i n  was 
s u s p e n d e d  in  a smal l  v o l u m e  of S T E  (100 m ~  NaC], 10 ms~ Tris-HC1 p H  7.5, 1 m ~  
E D T A )  a n d  d i s r u p t e d  w i t h  10 m~[ of NaC1 a n d  0.2 pe r  cen t  of T r i t o n  N 101. T h e  
d i s r u p t e d  v i r ion  was a d d e d  to  t he  r eac t i on  m i x t u r e  of a f inal  v o l u m e  of 50 ~zl, con- 
t a i n i n g  50 ms~ Tris-HC1 (pH 7.8), 100 m ~  KC1, 1 m ~  d i th io th re i to l ,  5 m ~  MgC12, 1 m ~  
t h r e e  r ibonuc leos ide  t r i p h o s p h a t e s ,  2 ~zCi 3 H - U T P  (specific a c t i v i t y  38.5 Ci /mmol)  
a n d  0.4 rns~ A p G  as a p r imer .  The  dup l i ca t e  samples  were  t h e n  i n c u b a t e d  a t  e i t he r  
25 ° or 33 ° C. The  r eac t ions  were t e r m i n a t e d  a t  va r ious  t i m e  i n t e rvMs  b y  t h e  a d d i t i o n  
of 1 ml  of cold 10 pe r  cen t  t roch loroaee t i e  ac id  (TCA) c o n t a i n i n g  0.1 ~ sod ium pyro-  
p h o s p h a t e .  Af te r  30 m i n u t e s  a t  0 ° C, t h e  p r e c i p i t a t e d  R N A  was col lected on  a W h a t m a n  
G F / C  fi l ter ,  a n d  t h e n  w a s h e d ;  f i rs t  w i t h  20 m l  of cold 5 pe r  c en t  TCA c o n t a i n i n g  0.1 ~ 
sod ium p y r o p h o s p h a t e  a n d  t h e u  w i t h  20 mI  of cold e thano l ,  l~ad ioac t iv i ty  was de ter -  
m i n e d  in  a sc in t i l l a t ion  s p e c t r o m e t e r  a f t e r  a d d i n g  5 ml  of aqueous  c o u n t i n g  se in t i l l an t  
(ACS I I ,  A m e r s h a m  Corp.).  
Preparation o] ~n]eeted Cell R N A  
M D C K  m o n o l a y e r  cu l tu res  g rown  in  75 c m  2 p las t ic  bo t t l e s  (2.2 × t07 cel ls /cul ture)  
were in fec ted  a t  a n  MOI  of 50 P F U / c e l l  in  t h e  presence  of 100 ~g/ml  eyc loheximide .  
Af te r  a d s o r p t i o n  for 30 m i n u t e s  a t  room t e m p e r a t u r e ,  t h e  inocu la  were r e m o v e d  a n d  
t h e  cu l tu re s  were w a s h e d  3 t imes  w i t h  10 m l  of cold H B S S .  T h e  v i rus  in fec ted  cells 
were  incubal~ed a t  25 ~' C for  5 h o u r s  or a t  33 ~ C for 3 h o u r s  in  t h e  g r o w t h  m e d i u m  as 
descr ibed  b y  SUGIU~A et al. (28) in  t he  presence  of 100 ~g/ml  cyc loheximide .  Zero t i m e  
cor responds  to  t he  t i m e  a t  wh ich  t he  in fec ted  cells were  b r o u g h t  to  t h e  a f o r e m e n t i o n e d  
temperatures. 
A t  l~he i n d i c a t e d  t imes ,  t h e  inSeeted cells were col lec ted  in to  re t i eu locy tes  s t a n d a r d  
buf fe r  (0.01 5I KCI, 0.0015 5I MAC12, 0.01 ~ Tris-HC1 p H  7.4), a n d  were e x t r a c t e d  5 to  
7 t i m e s  w i t h  pheno l -ch lo ro fo rm,  as descr ibed  p rev ious ly  (19). T h e  e t h an o l  p r e c i p i t a t e d  
I~NA was desa l t ed  fol lowed b y  c h r o m a t o g r a p h y  t h r o u g h  P D - 1 0  c o l u m n  (Sephadex  
G-25 ~ )  in  wate r .  The  R N A s  in t h e  exc luded  v o l u m e  were t h e n  pooled  a n d  lyophi l ized  
to  dryness .  
Quantitative Analysis o] Virus-speci]ie R N A  
M e a s u r e m e n t s  of v i rus  specific c o m p l e m e n t a r y  t {NA (cRNA) were  m a d e  b y  annea l -  
ing w i t h  3 H d a b e l e d  v i ra l  R N A  (3H-vRNA)  e x t r a c t e d  f rom pur i f i ed  v i r ion .  T h e  proce-  
dures  for  !gNA- lgNA a n n e a l i n g  e x p e r i m e n t s  were  b a s e d  on t h e  m e t h o d s  of GLASS 
et al. (9) a n d  K RUG et al. (12). T h r e e  m i c r o g r a m s  of 8 t t -v l~NA were m i x e d  w i t h  20 tzg 
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of virus-infected cellular lZNA in a final volume of 100 ,~1 of 2 × SSC in an Eppendorf 
tube. After boiling at 98 ° C for 5 minutes, the mixture was immersed in a 68 ° C water 
bath for 4 hours and then slowly cooled for 18 hours at 25 ° C. One-half of the sample 
was treated with 10 ixg/ml of pancreatic l%Nase and 50 units/ml of T 1 tZNase for 
30 minutes at 37 ° C .The other half was left untreated. The I{Nase resistant I~NA was 
determined as described previously (12). 
Synthesis o/ Viral Po~ypeptides 
Confluent MDCK monolayers were inoculated at an MOI of 50 PFU/cell for 30 min- 
utes at room temperature and then incubated in 2 × Eagle's medium at 25 ° C. At 
various times after infection, the medium was replaced with 1 ml of prewarmed 2 × 
Eagle's medium deficient in amino acids. After incubation for 45 m i n u ~ s  at 25 ° C, 
the infected cells were treated with 150 m~ NaC1 for 15 minutes before the addition 
of the radioactive label as described previously (15). The medium was removed and 
replaced with 0.2 ml of 2 X Eagle's medium deficient in amino acids and containing 
50 txCi/ml of laC-L-amino acid mixtures for exactly 20 minutes at  25 ° C. The labeling 
medium was then rapidly removed and cells were lysed in 100 ~xl of lysis buffer (14). 
Lysates were scraped from the culture tubes, boiled at 100 ° C for 1 minutes, sonicated, 
and frozen at - -20  ° C. 
Polyacrylamide Gel Electrophoresis (PAGE) 
Virus specific polypeptides in infected cells were analyzed by high-resolution 
discontinuous PAGE using Tris-glyeine buffer with SDS (13). This procedure was 
described previously in detail (23). 
Results 
Characteristics o/ Viral Growth at Various Temperatures 
I n  th i s  s t u d y ,  we a t t e m p t e d  to  d e t e r m i n e  t h e  stage(s)  i n  t he  v i r a l  
r e p l i c a t i o n  cycle w h i c h  a re  a f fec ted  b y  m u t a t i o n  of A / A A / 6 / 6 0  ca. v a r i a n t  
s t ra in ,  r e s u l t i n g  i n  e q u i v a l e n t  v i rus  y ie ld  a t  25 ° a n d  33 ° C as p r e v i o u s l y  
r e p o r t e d  b y  MAASSAB (17, 18). To  i n v e s t i g a t e  th i s  p h e n o m e n o n ,  i n f ec t ed  
cells were  in i t iMly  i n c u b a t e d  a t  33 ° C for 4 hours ,  fo l lowed b y  a t e m p e r a t u r e  
sh i f t  d o w n  to  25 ° C (Tab le  1). T h e  in fec t ious  pa r t i c l e s  of t h e  ca v a r i a n t  
a n d  A / A A / 6 / 6 0  w t  v i ru s  were d e t e c t e d  as ea r ly  as 6 hour s  a f t e r  the  te rn-  
p e r a t u r e  was  sh i f t ed  down .  T h e  t i t e r s  of t he  w t  v i r u s  a t  each  t i m e  i n t e r v a l  
Table 1. Virus production at 25 ° C after temperature shi/t-down /tom 33 ° C 
Virus titer (log t0 PFU/ml)  at indicated times (hours) 
Viruses 6 12 18 24 30 
A/A~4_/6/60 ca 3.0 4.0 5.0 5.2 5.9 
A/AA/6/60 wt 2.5 3.9 4.3 5.1 5.2 
MDCK monolayers were infected with the viruses at an MOI I0 PFU/oell and the 
aliquot samples were harvested at the indicated time intervals 
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Table 2. Virus production at 33 ° C after temperature shiJt-up ]rom 25 ° C a 
95 
Virus titer (log 10 PFU/ml)  at indicated times (hours) 
Viruses 3 6 9 12 
A/AA/6/60 ca 3.0 5.0 5.8 6.3 
A/AA/6/60 wt N.D. b 3.9 4.5 6.0 
Te36-3-1 4.1 5.3 5.7 6.3 
Immediat ly after infection, the infected cells were incubated at 25 ° C for 6 hours. 
The temperature was then elevated to 33 ° C 
b N.D. : not detected 
were  a l m o s t  equa l  to  those  of t h e  ca v a r i a n t  i n  sp i te  of be i ng  i n c u b a t e d  
a t  25 ° C. 
T a b l e  2 p r e sen t s  t he  resu l t s  of t e m p e r a t u r e  sh i f t - up  e x p e r i m e n t s  i n  
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Fig. 1. Comparison of in  vitro virion RNA potymerase activity at 25°C ( o - - -  --o) 
and 33 ° C ( . - - -  .) 
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incubation at 33 ° C. Viral production by the ca variant occurred 3 hours 
earlier than that  of A/AA/6/60 wt strain. The yield of the wt strain lagged 
behind until 12 hours after infection. Clone T2 36-3-1, which expresses ca 
phenotype and bears only the PB 2 gene from A/AA/6/60 ca variant with 
all remaining genes from wt A/Alaska/6/77 (Table 3), showed a viral growth 
pattern similar to that  of the ca variant virus. 
These experiments at  latered temperatures seem to suggest tha t  the 
ca mutation of A/AA/6/60 ca variant affects the early rather than late 
stage of viral replication, resulting in a high virus yield at 25 ° C. 
In vitro Virion R N A  Polymerase Ac t iv i t y  
To determine whether the ca mutation of A/AA/6/60 ca variant can be 
expressed as a phenotype with higher virion I~NA polymerase activity at 
25 ° C, the polymerase activity was analyzed by the incorporation of 3H- 
uridine triphosphates (3H-UTP). The kinetics of the enzyme activity of 
the ca reassortants and their parental viruses in 10 repeated determinations 
are shown in Fig. 1. Both A/AA/6/60 ca variant and A/AA/6/60 wt strains 
exhibited higher polymerase activity at 33 ° C, however, the enzyme activity 
of A/Alaska/6/77 virus was considerably lower (upper panels). The maximum 
activities (pieomoles UMP incorporated/mg protein) of these viruses were 
22.00, 18.86 and 8.40, respectively. Low enzyme activity at 33 ° C was also 
observed in the ca reassortants (lower panels). These ca reassortants possess 
a majority of gene segments originating from A/Alaska/6/77 strain (Table 3). 
Table 3. Gene constellations and biological properties o/ ca reassortant viruses a 
Viruses 
I~NA segments 
1 2 3 4 5 6 7 8 
Phenotypes (PA) (PB2) (PB1) (HA) (NA) (NP) (M) (NP) 
T236-3-I ca and non ts wt b AA c wt wt wt w~ wt wt 
T431-I-I ca and non ts wt AA wt w~ wt wt wt wt 
T48-7-I-I ca and non ts wt wt wt wt AA wt wt wt 
T66-2-1 ca and ts wt AA AA w~ AA wt w~ wt 
Taken from ODAGII~I et al. (23) 
b wt I~NA derived from A/Alaska/6/77 (H3N2) wild type virus 
c AA RNA derived from A/Ann Arbor/6/60 (tt2N2) ca variant virus 
Presumably the basis for depressed enzyme activity resides in these shared 
genes. This low enzymic activity at 33 ° C might be attr ibuted to the influence 
of matrix (M) protein of A/Alaska/6/77 strain as was previously shown for 
vesicular stomatitis virus (4) and also for influenza virus (33). Investigations 
are now in progress to explore this possibility. 
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Comparing the polymerase activity between 25 ° and 33 ° C in each strain, 
A/AA/6/60 ca variant  and the ca reassortants which possessed the PB2 
gene of the ca variant  (T6 6-2-1 and T4 31-1-1) exhibited similar patterns 
of enzyme activity at 25 ° and 33 ° C. This was in contrast to the polymerase 
activities of two wt virus and a ca reassortant, containing three polymerase 
genes from A/Alaska/6/77 (T4 8-7-1-1), which were markedly low at 25 ° C. 
These results clearly indicate tha t  the ca mutat, ion residing on the P B 2  
gene of the ca variant can be expressed as a phenotype of high polymerase 
act ivi ty at 25 ° as well as at  33 ° C. 
Synthesis o] Viral cRNA in the Primary Transcription 
For measurement of viral ct¢NA products synthesized in the pr imary 
txanscription, cRNA extracted from virus-infected cells, which were t reated 
with eycloheximide (CM) lrom the beginning of infection, was annealed 
with 3H-labeled virion RNA (3H-vt~NA). In preliminary experiments (data 
not  shown), the rate of appearance of cRNA of A/AA/6/60 ca variant  after 
infection reached a maximum between 4 and 6 hours at 25 ° C and between 
2 and 4 hours at 33 ° C. The transcripts gradually decreased with further 
incubation. These findings correlated with the results of maximum 3H- 
uridine incorporation into the infected cells at 5 hours (25 ° C) and 3 hours 
(33 ° C) in the presence of CM (data not shown). 
Table  4. Hybridization analysis o/viral cRNA synthesized in the presence o/cycloheximide 
e R N A  synthesized(tzg) • 
I~atio of c R N A  synthes ized  
to A/AA/6/60 ca va r i an t  
Viruses  a t  25 ° C at  33 ° C a t  25 ° C (%) at  33 ° C (%) 
A/AA/6/60 ca 0.225 0.236 100 100 
A/AA/6/60 wt  0.052 0.174 23.1 73.7 
T236-3-1 ca 0.195 0.167 86.7 70.8 
a Cytoplasmic  R N A  was ex t r ac t ed  a n d  annea led  to  3 ~g of 3I-I-uridine labeled viral  
R N A  (18,000 e p m / ~ g  lZNA to  48,500 e p m / ~ g  RNA).  The a m o u n t  of viral  I/.NA 
rende red  R N a s e  r e s i s t an t  af ter  anneMing represen ts  t h e  a m o u n t  of viral  el~NA 
syn thes i zed  in t h e  in fec ted  ceils 
The maximum amount  of cRNA synthesized by the ca and the wt viruses 
at  25 ° and 33 ° C is shown in Table 4. The production of eRNA by A/AA/6/60 
ca variant  was nearly equal at  25 ° an(t 33 ° C. The PB2-single gene ca 
reassortant T2 36-3-1 also exhibited similar properties, although its maximum 
products were approximately 15 to 30 per cent less at, each temperature  than 
the ca variant  strain. In  contrast, the cRNA products of A/AA/6/60 wt 
was significantly lower at  25 ° C than its products at  33 ° C. As a result, the 
amount  of cI~NA synthesized at 25 ° C was a quarter  of the amount  synthe- 
7 Arch. Virol. 88/1--2 
98 T. ODAGII~I, A. TOSAKA, N. ISttlDA, and E.  :F. MAASSAB : 
s i zed  b y  t h e  ca  v a r i a n t  a t  t h e  s a m e  t e m p e r a t u r e .  T h e s e  r e s u l t s  i n d i c a t e  that ,  
t h e  P B 2 - e a  m u t a t i o n  e n h a n c e s  v i r a l  p r i m a r y  t r a n s e N p t i o n  a t  low t e m -  
p e r a t u r e .  
P r e v i o u s l y ,  HAY et cd. (10) r e p o r t e d  t h a t  no  d e t e c t a b l e  s y n t h e s i s  of 
u n p o l y a d e n y l a t e d  c R N A ,  w h i c h  f u n c t i o n s  as a t e m p l a t e  for  v l ~ N A  syn the s i s ,  
Fig. 2. Viral polypeptides trar~slated from viral  eRNA synthesized at  25°C in the 
presence of cyeloheximide (CM). MDCK cells were infected at  an MOI of 50 PFU/cell  
in the presence of 100 ~.g/mt CM and incubated for 3 hours at  25 ° C in the presence 
of CM. The cells were then t reated with 2 ~zg/ml aetinomyein D for 1 hour at  25 o C. 
After removal of the drugs, the cells were incubated for 4 hours at  33 ° C and labeled 
with 30 ~Ci/ml i4C-L-amino acid mixtures for 20 minutes, as described in Materials 
and  Methods. The samples were subjeeted to electrophoresis on a 10 per cent gel and 
fluorographed for 7 days at  --  80 ° C. ca A/AA/6/60 ea var iant  ; wt A/AA/6/60 wt  strain;  
A L  A/Alaska~6~77 wt strain;  el. 36 T236-3-1 ca reassortant  
o c c u r r e d  in  i n f e c t e d  cells t r e a t e d  w i t h  CM f r o m  t h e  b e g i n n i n g  of in fec t ion .  
Thus ,  t h e  c R N A  m e a s u r e d  in  t h i s  p r i m a r y  t r a n s c r i p t i o n  e x p e r i m e n t s  
r e p r e s e n t e d  m e s s e n g e r  I~NA ( m R N A ) .  To d e m o n s t r a t e  w h e t h e r  t h e  t r a n -  
s c r i p t s  s y n t h e s i z e d  u n d e r  o u r  e x p e r i m e n t a l  c o n d i t i o n s  f u n c t i o n  as  m R N A  
in  i n f e c t e d  cells,  we  u n d e r t o o k  p r i m a r y  t r a n s l a t i o n  e x p e r i m e n t s .  I n f e c t e d  
cel ls  we re  i n c u b a t e d  a t  25 ° C for  3 h o u r s  in  t h e  p r e s e n c e  of  CM a n d  t h e  cel ls  
we re  s u b s e q u e n t l y  t r e a t e d  w i t h  a e t i n o m y c i n  D fo r  1 h o u r  a t  25 ° C to  b l o c k  
f u r t h e r  e I~NA s y n t h e s i s  (26). T h e  t r a n s c r i p t s  s y n t h e s i z e d  u n d e r  l i m i t e d  
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conditions by actinomycin D were translated in the cells after removal of 
the drugs at 33 ° C for 4 hours as shown in Fig. 2. The temperature of 33 ° C 
was chosen to avoid any differences in the translation rate between the ea 
mutants  and the wt viruses. The relative amount of the ca variant and the 
PB 2 single-gene reassortant translates were greater than those of the wt 
viruses. 
The finding suggests tha t  the primary tremscripts ~ffected by the PB2- 
ca, mutation were mainly, if not all, m~NA. 
Synthesis o/ Viral Polypeptides at 25 ° C 
Viral polypeptides synthesis in the virus-infected cells at 25 ° C was 
characterized at  various times post-infection (p.i.). Polypeptide synthesis 
Fig. 3. Synthes is  of viral po lypep t ides  a t  25°C in v i rus- infec ted  M D C K  cells. The 
infec ted  cells were  i ncuba ted  at  25 ° C for the  hours  ind ica ted  at  the  top  of each column.  
Tile samples  labeled,  as descr ibed in Materials  and  Methods ,  were sub jec ted  to eleetro- 
phoresis  on a l0 per  cent  gel and  f tuorographed  for 14 days  a t  - -80  ° C. U un in fec ted  
cell; A A/AA/6/60  ca va r i an t ;  B A/AA/6/60 wt  s t ra in  
7* 
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at 33 ° C which corresponds to normal infection was also examined. At this 
temperature the polypeptides of both ca. variant and the wt  viruses were 
detected at 2 hours p.i., with no significant differences in the amount of 
products observed (data not shown). However, at 25 ° C the time required 
for the appearance of each viral potypeptide was markedly different as can 
be seen in Fig. 3. The nueleoprotein (NP) and nonstruetural proteins (NS) 
of the ca variant were detected at  6 hours p.i. (lane 6A). These polypeptides 
were gradually accumulated under subsequent incubation at 25 ° C. The 
M protein of the ca variant was detected at 10 hours p.i. (lane 10A) and all 
of the potypeptides attained their maximum levels by  18 hours p.i. (lane 
18A). On the contrary, no visible viral polypeptide synthesis of the wt strain 
was observed until 10 hours p.i. (lanes 4 B to 10 B), with synthesis becoming 
significant from 12 hours p.i. (lane 12B). 
Rough quantitative comparison of the polypeptide products of these 
two viruses was also performed by  densitometer tracing. The total amount 
of wt  viral polypeptide synthesized at 24 hours p.i. was calculated to be 
approximately 56 per cent of the polypeptide synthesized by the ca variant. 
In addition, the polypeptide synthesis of the wt  virus at  24 hours p.i. 
corresponded to that  of the ca variant at 18 hours p.i. (compare lanes 18A 
and 24 B). 
Discussion 
A ca mutation contributing to the ca property of A/AA/6/60 variant 
strain was identified as residing on the PB 2 gene of the variant strain by  
the following findings; i) some ca mutants  which expressed only ca pheno- 
type were "PB 2 single-gene" reassortant viruses (23) and ii) electrophoretie 
analysis of viral polypeptides in infected cells at 33 ° C showed that  only the 
PB 2 protein of A/AA/6/60 variant migrated more slowly than that  of the 
wt strain (unpublished data). The present s tudy is the first a t tempt  to 
delineate the function of the ca mutation(s) residing on the P B 2  gene 
(PB2-ea mutation) of the ca variant strain using the P B 2  single-gene 
reassortant virus. 
The comparative analysis of viral growth curves from temperature shift 
experiments indicated that  A/AA/6/60 ca variant grew equally well at  25 ° 
and 33 ° C regardless of any shifts in the incubation temperature. This was 
not true with the wt  virus whose growth was markedly delayed and whose 
yield was depressed when the wt virus-infected ceils were placed at the low 
temperature during the early stage of the viral replication. This phenomenon 
correlated with the finding that  at 25 ° C synthesis of the wt polypeptides 
occurred 6 hours later than synthesis of the ca variant polypeptides and 
that  the maximum polypeptide production was only half of the ca variant  
product. The fact that  the ca virus' growth range is expanded to 25 ° C 
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strongly suggests that  at least one of the ca mutations of the ca variant 
strains plays an important role in the early stage of viral replication. 
The optimal temperature for in vitro enzyme activity of virion RNA 
polymerase is reported to be between 31 ° and 33 ° C (2). At 25 ° C the activities 
of any influenza wt strains do not surpass their activities at  the optimal 
temperature (11, 22). The ca A/AA/6/60 variant and any ca reassortants 
containing the A/AA/6/60 PB 2 gene, however, exhibited identical activities 
at both 25 ° and 33 ° C in our assay. The low polymerase activity of A/Alaska/ 
6/77 wt strain at 25 ° C increases until it reaches a level similar to tha t  at 
33 ° C if the PB2 gene of A/Alaska/6/77 is exchanged for the PB2 gene of 
the ca variant by genetic reassortment, as can be seen for T4 31-1-1. From 
the in vitro polymerase assays, it was apparent tha t  the PB 2 gene of A/AA/ 
6/60 ca variant strain can affect the phenotype of enzyme activity at 25 ° C. 
In addition, A/AA/6/60 ca variant 's polymerase in the temperature-sensitive 
property was considerably more heat labile than the wt polymerase when 
treated for 10 minutes at 39 ° C and this thermal lability is attributed to the 
PB 2 protein of the ca variant strain (in preparation). 
Because the ca variant and the reassortants containing only the PB2 
gene from A/AA/6/60 synthesized polypeptides in twice the abundance of 
the wt virus' in infected cells at 25 ° C ,we were led to predict tha t  at 25 ° C 
the virus strains containing the PB 2-ca mutation would synthesize a greater 
amount of mI~NA than the wt strain. Both unpolyadenylated cRNA and 
vRNA are not detected in the presence of eycloheximide (CM) (1, 20). 
Therefore, quantitative analysis of viral cRNA synthesized in the presence 
of CM in our experiments demonstrated tha t  the ea variant (A/AA/6/60) 
produced equal amount of cl~NA at 25 ° and 33 ° C and that  this amount 
was approximately four-fold greater than the wt cl~NA synthesized at 25 ° C. 
The PB 2 single-gene reassortant virus acted in a similar manner. Thus the 
evidence strongly suggests tha t  the PB 2-ca mutation was expressed at the 
first step in viral mRNA synthesis at 25 ° C. When viral mRNA is synthesized, 
the PB 2 protein functions in recognition and binding of the cap 1 structure 
as a primer during the endonuclease reaction (3, 30, 31). 
Using the methods of T1 oligonueleotide mapping and RNA-RNA 
hybridization, Cox et al. (7) showed that  A/AA/6/60 ca variant strain 
possesses mutations in all eight gene segments. I t  is not clear whether the 
ca mutation on the PB 1 gene segment of the ca variant affects the initiation 
and elongation step in viral mRNA synthesis caused by PB 1 protein (3). 
Furthermore the ca mutation on the A/AA/6/60 variant neuraminidase (NA) 
gene tha t  presumably functions in the late stage of the viral replication 
remains to be determined. However, the assessment of the ca mutations 
using the single-gene reassortants of A/AA/6/60 variant strain as shown 
in the present study can be a useful approach in clarifying the mechanism 
of viral replication at low temperature. 
102 T. ODAGIRI, A. TOSAJ~A, N. ISlIIDA, and H. F. MAASSAB: 
Aeknowledgments 
We thank Drs. K. Shimizu and D. C. DeBorde, and Mr. A. Donabedian for their 
in valuable discussions. This work was supported by Grants in aid for Scientific 
Research from the Ministry of Education, Science and Culture, and from the Ministry 
of Pubtie Health and Welfare of Japan. tI.]?.M, was supported by Contract No. 1-AI- 
72521, National Inst i tute  of Allergy and Infectious Diseases, Development and 
Applications Branch, Bethesda, Maryland 29205, U.S.A. 
References 
1. BARR~TW, T., ~VOLSTE~T~ZOLM~, A. J., MA~Y, t3. VV. : Transcription and replication 
of influenza virus RNA. Virology 98, 211---225 (1979). 
2. BISHOP, D. H. L., OBI~s~I,  J. F., SImPson, R. W. : Transcription of the influenza. 
ribonueleie acid genome by a virion polymerase. I. Optimal conditions for in vitro 
activity of the ribonucleie acid dependent ribonueleie acid potymerase. J. Viroh 8, 
66--73 (I971). 
3. BRAA~, J., ULSIANE~', I., KR~TG, R, M. : Moleeular model of a euearyotie tran- 
scription complex : Functions and movements of influenza P proteins during capped 
l~NA-primed transcription. Cell. 34, 609-618  (1983). 
4. CARROL, A. R., WAGNEr, R. R. : Role of the membrane (M) protein in endogenous 
inhibition of in vitro transcription by vesicular stomatitis virus. J. Viroh 29, 
134~-142 (1979). 
5. CLE?CIENTS, M. L., 0'DONNELL, S., LEVINE, M. M., CHANOCK, R. M., MuaPHr, B. R. : 
Dose response of A/Alaska/6/77 ( t t3N2) cold-adapted reassortant vaccine virus 
in adalt volunteers: Role of local antibody in resistance to infection with vaccine 
virus. Infect. Immun.  40, 1044--1051 (1983). 
6. Cox, N. J., MAASSAB, H. F., KE~DAI;, A. P. : Comparative studies of wild-type and 
cold-mutant (temperature sensitive) influenza viruses : Nonrandon reassortment of 
genes during preparation of live virus vaccine candidates by recombination at 
25 ° C between recent H 3N 2 and t t  1 N 1 epidemic strains and cold-adapted A/Ann 
Arbor/6/60. Virology 97, 190--194~ (1979). 
7. Cox, N. J., KoN~Ec~:, I., KE~DAJ~, A. P., MAASSA~, H. F. : Genetic and biochemical 
analysis of the A/Ann Arbor/6/60 cold-adapted mutant .  In :  NAYA~:, D. (ed.), 
Genetic Variation among Influenza Viruses, 639--652. New York: Academic Press 
1981. 
8. Cox, N. J., KESTDAL, A. P.: Genetic stability of A/Ann Arbor~6~60 cold-mutant 
(temperature-sensitive) live influenza virus genes: Analysis by oligonucleotide 
mapping of recombinant vaccine strains before and after replication in volunteers. 
J.  Infect. Dis. 149, 194--200 (1984). 
9. GLASS, S. E., MeG]~ocH, D., BARRY, ]~. D.: Characterization of the ml~NA of 
influenza virus. J. Virol. 16, 1435----t4A3 (1975). 
10. HAY, A. J., LOMNICZI, B., BELLAMY, A. R., SKEHEn, J. J. : Transcription of the 
influenza virus genome. Virology 83, 337--355 (1977). 
11. KENDAL, A. P., Cox, N. J., GALPItlN, J. C., MAASSAB, H. F. :  Comparative studies 
of wild-type and cold-mutant (temperature-sensitive) influenza viruses: Inde- 
pendent segregation of temperature-sensitivity of virus replication from temper- 
ature-sensitivity of vJrion transeriptase activity during recombination of mutan t  
A/Ann Arbor/6/60 with wild-type t t 3 N 2  strains. J. gen. Virol. 44, 443--456 
(1979). 
12. KRuo, R. M., UEDA, M., PALESE, P. : Temperature-sensitive mutants  of influenza 
WSN virus defective in virus-speeifie RNA synthesis. J. Viroh 16,790--796 (1975). 
Influenza A Virus ca Mutation 103 
13. LAENMLI, U. K. : Cleavage of structural protein during the assembly of the heat 
of bacteriophage T4. Nature (London) 227, 680---685 (1970). 
14. LAsIB, A. II.., CHOPPIN, P. W. : Synthesis of influenza virus proteins in infected 
cells : Translation of viral polypeptides, including three P polypeptides from R.NA 
produced by primary transcription. Virology 74, 504--5t9 (1976). 
15. LAN~, R. A., ETKIND, P. 1%., CItoPPISr, P. W. : Evidence for a ninth  influenza viral 
polypeptide. Virology 91, 60--78 (1978). 
16. MAASSAB, It .  F. : Adaption and growth characteristics of influenza virus at 25 ° C. 
Nature (London) 213, 612--614 (1967). 
17. MAASSAB, H. F. : Biologic and immunologic characteristics of cold-adapted influenza 
virus. J. Immtmol. 102, 728--732 (1969). 
18. MAASSAB, }I. F. : Development of variants of influenza virus. In :  BARRY, g .  D., 
M~A~Y, B. W. J. (eds.), The Biology of Large tR, NA Viruses, 542--566. New York: 
Academic Press 1970. 
19. MAASSAB, H. F., DEBO•DE, D. C.: Characterization of influenza A host range 
mutant .  Virology 13t), 342--350 (1983). 
20. MARx, G. E., TAYLOR, J. M., BROXI, B., Kau¢,  R. M. : Nuclear accumulation of 
influenza viral RNA transcripts and the effects of eyeloheximide, aetinomyein D, 
and ~-amamitin. J. Virol. 29, 744--752 (1979). 
21. MoRi~rz, A. J., KUNZ, C., HOFMAI% II., LIEtII, E., ]~EEV, P., MAASSAB, It.  F. :  
Studies with a cold-recombinant A/Victoria/3/75 (It 3N2) virus. I I .  EvMuation in 
adult  volunteers. J. I~ffect. Dis. 142, 857--860 (1980). 
22. MowsHowITz, S. L., UEDA, M. : Temperature-sensitive virion transeriptase activity 
in mutan ts  of WSN influenza virus. Arch. ViroI. 52, 135--141 (1976). 
23. ODACI~.I, T., DEBoRDE, C. D., MAASSAB, I-I. F. : Cold-adapted reeombinants of 
influenza A virus in MDCK cells. I. Development and characterization of A/Ann 
Arbor/6/60 × A/Alaska/6/77 recombinant viruses. Virology 119, 82---95 (1982). 
24. ODAGIRI, T., S~ITKA, C. YV., M~SSAB, tI.  F. : Cold-adapted reassortants of influenza 
A virus in MDCK cells. II .  Role of the temperature-sensitive property of cold- 
adapted in mice. Mierobio]. Immunol.  27, 203--206 (1983). 
25. PLOTCH, S. J., KRvG, R. M. : Influenza virion transeriptase : Synthesis i n  vitro of 
large, polyadenylic acid-containing complementary RNA. J. Virol. 21, 24--34 
(1977). 
26. PoNs, M. W.: Early RNA synthesis in influenza virus-infected cells. Virology 76, 
855--859 (1977). 
27. S~I~G,  S. B., MAASSAB, I-I. F., K~NDAL, A. P., MuttPJ~Y, B. 1~., CHANOCK, 1~. M. : 
Cold-adapted variants of influenza A. II .  Comparison of the genetic and biological 
properties of ts mutat ions and recombinants of the cold-adapted A/AA/6/60 strain. 
Arch. Virol. 55, 233--246 (1977). 
28. SUGIURA, A., UEDA, M., TOBITA, K., ENONOTO, C. : Further isolation and charac- 
terization of temperature-sensitive mutations of influenza virus. Virology 65, 
363--373 (1975). 
29. TA~rNOCK, G. A., PAUL, J. A., BARRY, R. D. : Relative immunogenieity of the 
cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60) reeombinants of 
A/AA/6/60-ea, and parental strains with similar surface antigens. Infect. Immun.  43, 
457--462 (1984). 
30. UL~ANE~, I., B~O~I, B. A., KRUG, 1R,. M. : Role of two of the influenza virus core 
P proteins in recognizing cap 1 structures (mVGpppNm) on I~NAs and in initiating 
viral RNA transcription. Prec. Natl. Acad. Sei. U.S.A. 78, 7355--7359 (1981). 
31. ULMANEN, I., Bt~ONI, B., KI~UG, t~. M. : Infhlenza virus temperature-sensitive cap 
(mVGpppNm)-dependent endonuclease. J. Virol. 45, 27--35 (1983). 
!04 T. ODAOIRI, A.TOSAKA, ~. ISIIIDA: and I-I. F. MAASSAB : InfluenzaAVirus calViutation 
32. YA:~A~'E, N., NAKAMURA, W., YUKI, M., ODAGIRI, T., IStIID&, N.:  Serological 
evaluation of an influenza A virus cold-adapted reassortant  live vaccine, CR-37 
(H I N  1), in Japanese adul t  volunteers. J. I-Iyg. (Camb.) 92,231--242 (1984). 
33. ZVO~rARJEV, A. Y., GtIENDOlg, Y. Z.: Influence of membrane (M) protein on 
influenza. A virus virion transcrJptase ac t iv i ty  in  vitro and its susceptibil i ty to 
r imantadine.  J .  ViroI. 33, 583--586 (1980). 
Authors '  address: Dr. T. 0DAGIRI, Depar tment  of Virology, Jichi Medical School, 
Minamikawachi-maehi,  Kawaehi-gun, Tochigi-ken, 329-04 Japan.  
t~eceived ~Iareh 8, 1985 
